Cat.No. | Name | Information |
---|---|---|
M5735 | Leuprolide Acetate | Leuprolide acetate is a GnRH analog; leuprolide acetate acts as an agonist at pituitary GnRH receptors. |
M53114 | LHRH | LHRH, the luteinizing hormone-releasing hormone, is a neuropeptide hypothalamic. |
M45271 | Ganirelix acetate | Ganirelix acetate is a competitive gonadotropin-releasing hormone (GnRH) antagonist that directly binds to endogenous molecules competing for the receptor and causes a rapid decrease in estradiol levels. Ganirelix acetate can be used in studies related to ovarian hyperstimulation syndrome (OHSS) and preterm labor. |
M31385 | Gonadorelin acetate | Gonadorelin acetate is a decameric synthetic oligopeptide that is also a gonadotropin-releasing hormone (GnRH) agonist. |
M31382 | Triptorelin acetate | Triptorelin acetate is a synthetic decapeptide analog of luteinizing hormone-releasing hormone (LHRH) and a gonadotropin-releasing hormone (GnRH) agonist. |
M30666 | (R)-Elagolix | Elagolix is a highly potent, selective, orally-active, short-duration, non-peptide antagonist of the gonadotropin-releasing hormone receptor (GnRHR) (KD = 54 pM). Target: GnRH in vitro: Elagolix is a short-acting, nonpeptide, GnRH antagonist, administered orally, that unlike injectable depot GnRH agonists and antagonists, produces a dose-dependent suppression of ovarian estrogen production, that is, from partial suppression at lower doses to full suppression at higher doses. Elagolix is regarded as the frontrunner of a new class of GnRH inhibitors that have been denoted as second-generation, due to their non-peptide nature and oral bioavailability. |
M22414 | Buserelin Acetate | Buserelin Acetate |
M21021 | Nafarelin Acetate | Nafarelin Acetate is a Gonadotropin-releasing hormone (GnRH) agonist; synthetic decapeptide analog of GnRH (luteinizing hormone-releasing hormone, gonadorelin); structurally related to goserelin, leuprolide, and triptorelin. |
M21020 | Leuprorelin | Leuprorelin is a natriuretic peptide analog of GnRH and a pituitary GnRH receptor agonist. It can be used in studies related to estrogen receptor (ER)-positive premenopausal breast cancer. |
M13378 | Antide | Sequence:Ac-D2Nal-DCpa-DPal-Ser-Lys(nicotinoyl)-DLys(nicotinoyl)-Leu-Lys(isopropyl)-Pro-DAla-NH2 |
M13376 | Abarelix | Abarelix (R3827) is the first approved antagonist for the study of GnRH in advanced prostate cancer. Sequence:Ac-{d-2-Nal}-{d-4-Cpa}-{d-3-Pal}-S-{NMyr}-{d-Asp}-L-K(ipr)-P-{d-Ala}-NH2 |
M13375 | Cetrorelix Acetate | Cetrorelix Acetate (SB-75 acetate) is a potent gonadotropin-releasing hormone (GnRH) receptor antagonist with an IC50 of 1.21 nM. Sequence:Ac-D2Nal-D4Cpa-D3Pal-Ser-Tyr-DCit-Leu-Arg-Pro-DAla-NH2 |
M13374 | Ganirelix | Sequence: Ac-D-2-Nal-D-Phe(4-Cl)-D-3-Pal-Ser-Tyr-D-Lys(C(NHEt)2)-Leu-Lys(C(NHEt)2)-Pro-D-Ala-NH2 |
M10505 | Histrelin acetate | Histrelin is a nonapeptide analog of GnRH (gonadotropin-releasing hormone) with added potency. |
M10477 | Linzagolix | Linzagolix is a novel potent, orally active gonadotropin-releasing hormone (GnRH) antagonist. |
M10250 | Degarelix (GSK1278863) | Degarelix (GSK1278863) is a third generation antagonist of luteinizing hormone-releasing hormone (LHRH, also termed gonadotropin-releasing hormone) for the first-line treatment of androgen-dependent advanced prostate cancer. |
M9197 | Relugolix | Relugolix, also known as TAK-385, is an orally active gonadotropin-releasing hormone (GnRH) antagonist with an IC50 of 0.12 nM. |
M5391 | Alarelin Acetate | Alarelin acetate is a synthetic GnRH agonist. Alarelin is found in higher amounts than that of LH-RH in rat hypophyseal stimulation of gonadotropin secretion in vivo and in vitro and in ovulation inductions. |
M5291 | Sufugolix | Sufugolix (TAK-013) is a highly potent and orally available luteinizing hormone-releasing hormone LHRH receptor antagonist with an IC50 of 0.1 nM. |
M1836 | Deslorelin Acetate | Deslorelin is an injectable gonadotropin releasing hormone super-agonist (GnRH agonist) also known as an LHRH agonist. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.